Skip to main content

Table 2 Whole Genome Sequencing predicted antibiotic susceptibility for 33 non-duplicate GBS isolates (See Supplemental Table 1 for MIC prediction values)

From: Whole genome sequence based capsular typing and antimicrobial resistance prediction of Group B streptococcal isolates from colonized pregnant women in Nigeria

Antibiotic

Targeted genes

Susceptible (%)

Non-Susceptible *(%)

Ampicillin

pbp2X

33 (100)

-

Ceftriaxone

pbp2X

33 (100)

-

Chloramphenicol

cat

25 (75.6)

8 (24.2)

Clindamycin

erm

25 (75.6)

8 (24.2)

Ceftaroline

pbp2X

33 (100)

-

Erythromycin

erm or mef

23 (69.7)

10 (30.3)

Levofloxacin

parC, gyrA

24 (72.7)

9 (27.3)

Meropenem

pbp2X

33 (100)

-

Linezolid

23 S rRNA

33 (100)

-

Penicillin

pbp2X

33 (100)

-

Synercid**

erm + lsa

33 (100)

-

Cefotaxime

pbp2X

33 (100)

-

Tetracycline

tet

-

33 (100)

Vancomycin

van

33 (100)

-

  1. ** Quinupristin/Dalfopristin
  2. *Non-susceptibility includes both intermediate and resistant prediction